RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
@TheCynicalHun @LeeLegalize Flares can happen with the vaccine which is unfortunate but that, of course doesn’t imply they aren’t effective or hugely beneficial https://t.co/YHLtWXzdkX
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey https://t.co/Ns8iKBtTxD
we learned a lot about vaccination (immunogenicity & reactogenicity) in people w RMDs https://t.co/QPrEkB90m7 https://t.co/VHZC90MAME https://t.co/AUPZuBeAiZ #EULAR2022
4. I do believe that the vaccines (very) rarely cause immune side effects (ie GBS et al) and I 100% believe they can cause flares of existing disease. Have seen that myself and co-authored multiple papers on this topic: https://t.co/m9Qg3E91zo https://t.
RT @PittICRE: CEED scholar & assistant prof, Dr. Sattui Cortes @SattuiSEMD publishes articles on the outcomes of COVID-19 in patients w/ pr…
RT @PittICRE: CEED scholar & assistant prof, Dr. Sattui Cortes @SattuiSEMD publishes articles on the outcomes of COVID-19 in patients w/ pr…
@PittRheum @PittDeptofMed
RT @PittICRE: CEED scholar & assistant prof, Dr. Sattui Cortes @SattuiSEMD publishes articles on the outcomes of COVID-19 in patients w/ pr…
CEED scholar & assistant prof, Dr. Sattui Cortes @SattuiSEMD publishes articles on the outcomes of COVID-19 in patients w/ primary systemic vasculitis & early experience of COVID-19 vaccines in adults w/ systemic rheumatic diseases. https://t.co/6B
RT @AriellaStudies: Direct link to original scientific article in @ARD_BMJ: https://t.co/SkO86ed5jF #MedTwitter #RheumTwitter #RheumaticD…
Direct link to original scientific article in @ARD_BMJ: https://t.co/SkO86ed5jF #MedTwitter #RheumTwitter #RheumaticDisease #COVID19 3/3 🧵 https://t.co/tzfR8cBWEO
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
Recommended reading by the Editor, related to topics covered at #ACR21: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases 📝 Check it out now #ACR21 https://t.co/xeypvjSZQ5
RT @ArmenYuri: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheuma…
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey https://t.co/Ns8iKBtTxD
@Momonamission78 @Mariebe10098426 @PoliticsPollss Yeah of only they were available. I can write too. https://t.co/TBAOi0O7Ip https://t.co/p763MTwW3i
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @WallaceUofE: Proud to be associated with @rheum_covid on this important publication for the rheumatic community. Early experience of C…
@ShieldUs1 @DmodosCutter Btw, here's a paper we published today which may be interesting. https://t.co/TBAOi0wwjP
RT @RichAHoward: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheu…
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey #spondylitis https://t.co/cAYqnCQBRo
Proud to be associated with @rheum_covid on this important publication for the rheumatic community. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
RT @jeffsparks: Such a pleasure to work on this @rheum_covid study with @SattuiSEMD @rheum_cat @RheumEpi @hausmannMD and many others. 2860…
Open Access UCL Research: Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey https://t.co/cpc518n5t6
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @AAlliance_SAID: Thanks to all involved. It was an honor to be a part of this project, and always a pleasure collaborating with all in @…
Thanks to all involved. It was an honor to be a part of this project, and always a pleasure collaborating with all in @rheum_covid. Well done!
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
RT @philipcrobinson: The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC…
The first paper from the COVID-19 Global Rheumatology Alliance Vaccine Survey from @ARD_BMJ https://t.co/f2kqrD7pbC @rheum_covid Thank you 🙏Huge team effort. More data on the way 😃
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
Informe sobre los resultados de la @rheum_covid#vaccine encuesta entre personas con #RMDs
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
RT @deshire_alpizar: Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirier…
Información sobre perspectiva de 2860 pacientes con enfermedades reumáticas sobre vacunas COVID-19. Sólo 4.6% refirieron exacerbaciones que requirieron cambios en tratamiento. Chequen la publicación 🔽
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
RT @ARD_BMJ: Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4…
Report on the results of the @rheum_covid #vaccine survey among people with #RMDs The perspective of 2860 patients. In only 4.6% disease flares requiring medication changes were stated. Many more details like willingness for medication adaptions: https:/
@Emor67 @mgizquierdo @RaquelAlmodovaG Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Glob… https://t.co/nJchsBa2XX
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @jeffsparks: Such a pleasure to work on this @rheum_covid study with @SattuiSEMD @rheum_cat @RheumEpi @hausmannMD and many others. 2860…
RT @jeffsparks: Such a pleasure to work on this @rheum_covid study with @SattuiSEMD @rheum_cat @RheumEpi @hausmannMD and many others. 2860…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
I will read later
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @RichardPAConway: Very proud to be part of this study, along with @Eimear3D from @stjamesdublin . Fantastic team 👏
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
Very proud to be part of this study, along with @Eimear3D from @stjamesdublin . Fantastic team 👏
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
Such a pleasure to work on this @rheum_covid study with @SattuiSEMD @rheum_cat @RheumEpi @hausmannMD and many others. 2860 adults with rheumatic diseases who received COVID vaccination up until 30 April 2021
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
RT @SattuiSEMD: 🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @…
🚨#GRA Vax Survey @rheum_covid First publication out in @ARD_BMJ !🚨 2860 adults with SRD who received at least one dose 💉 @jeffsparks @rheum_cat @RheumEpi @EBRheum @hausmannMD @emilysirotich @KMacKennedy and many others Available: https://t.co/YMD0nYFQNp